New trial aims to find safer treatment for dangerous scar pregnancy
NCT ID NCT07288307
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for caesarean scar pregnancy, a rare but serious condition where a pregnancy implants in a previous C-section scar. Forty-two women will receive either ultrasound-guided surgical removal or a combination of local and systemic methotrexate. The goal is to see which approach works better with fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methotrexate
- What this could lead to
- If successful, this could identify a safer, more effective standard treatment for caesarean scar pregnancy, reducing complications like severe bleeding.
- What could go wrong
- This is a small Phase 2 trial with only 42 participants, so results may not apply to everyone. Both treatments carry risks of bleeding, infection, or need for additional procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAESAREAN SCAR PREGNANCY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.